» Articles » PMID: 33384857

Bacterial Type II Toxin-antitoxin Systems Acting Through Post-translational Modifications

Overview
Specialty Biotechnology
Date 2021 Jan 1
PMID 33384857
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The post-translational modification (PTM) serves as an important molecular switch mechanism to modulate diverse biological functions in response to specific cues. Though more commonly found in eukaryotic cells, many PTMs have been identified and characterized in bacteria over the past decade, highlighting the importance of PTMs in regulating bacterial physiology. Several bacterial PTM enzymes have been characterized to function as the toxin component of type II TA systems, which consist of a toxin that inhibits cell growth and an antitoxin that protects the cell from poisoning by the toxin. While TA systems can be classified into seven types based on nature of the antitoxin and its activity, type II TA systems are perhaps the most studied among the different TA types and widely distributed in eubacteria and archaea. The type II toxins possessing PTM activities typically modify various cellular targets mostly associated with protein translation and DNA replication. This review mainly focuses on the enzymatic activities, target specificities, antitoxin neutralizing mechanisms of the different families of PTM toxins. We also proposed that TA systems can be conceptually viewed as molecular switches where the 'on' and 'off' state of the system is tightly controlled by antitoxins and discussed the perspective on toxins having other physiologically roles apart from growth inhibition by acting on the nonessential cellular targets.

Citing Articles

The HicAB System: Characteristics and Biological Roles of an Underappreciated Toxin-Antitoxin System.

Encina-Robles J, Perez-Villalobos V, Bustamante P Int J Mol Sci. 2024; 25(22).

PMID: 39596231 PMC: 11594946. DOI: 10.3390/ijms252212165.


Phosphorylation of VapB antitoxins affects intermolecular interactions to regulate VapC toxin activity in .

Malakar B, Barth V, Puffal J, Woychik N, Husson R J Bacteriol. 2024; 206(10):e0023324.

PMID: 39315797 PMC: 11500542. DOI: 10.1128/jb.00233-24.


Phosphorylation of VapB antitoxins affects intermolecular interactions to regulate VapC toxin activity in .

Malakar B, Barth V, Puffal J, Woychik N, Husson R bioRxiv. 2024; .

PMID: 38853858 PMC: 11160731. DOI: 10.1101/2024.05.30.596101.


Focused Overview of VapBC Toxin-Antitoxin Systems Regarding Their Structural and Functional Aspects: Including Insights on Biomimetic Peptides.

Kang S Biomimetics (Basel). 2023; 8(5).

PMID: 37754163 PMC: 10526153. DOI: 10.3390/biomimetics8050412.


The DarT/DarG Toxin-Antitoxin ADP-Ribosylation System as a Novel Target for a Rational Design of Innovative Antimicrobial Strategies.

Catara G, Caggiano R, Palazzo L Pathogens. 2023; 12(2).

PMID: 36839512 PMC: 9967889. DOI: 10.3390/pathogens12020240.


References
1.
Cheverton A, Gollan B, Przydacz M, Wong C, Mylona A, Hare S . A Salmonella Toxin Promotes Persister Formation through Acetylation of tRNA. Mol Cell. 2016; 63(1):86-96. PMC: 4942678. DOI: 10.1016/j.molcel.2016.05.002. View

2.
Ree R, Varland S, Arnesen T . Spotlight on protein N-terminal acetylation. Exp Mol Med. 2018; 50(7):1-13. PMC: 6063853. DOI: 10.1038/s12276-018-0116-z. View

3.
Wang Y, Peterson S, Loring J . Protein post-translational modifications and regulation of pluripotency in human stem cells. Cell Res. 2013; 24(2):143-60. PMC: 3915910. DOI: 10.1038/cr.2013.151. View

4.
Levinson N, Seeliger M, Cole P, Kuriyan J . Structural basis for the recognition of c-Src by its inactivator Csk. Cell. 2008; 134(1):124-34. PMC: 2494536. DOI: 10.1016/j.cell.2008.05.051. View

5.
Moyed H, Bertrand K . hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol. 1983; 155(2):768-75. PMC: 217749. DOI: 10.1128/jb.155.2.768-775.1983. View